The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 15 , ISSUE 6 ( November-December, 2014 ) > List of Articles

REVIEW ARTICLE

Evaluation of Medicinal Interventions for the Management of Oral Submucous Fibrosis: A Systematic Review of the Literature

Kamran Habib Awan, Syed Rashid Habib, Ana Pejcic, Rosnah Binti Zain

Citation Information : Awan KH, Habib SR, Pejcic A, Zain RB. Evaluation of Medicinal Interventions for the Management of Oral Submucous Fibrosis: A Systematic Review of the Literature. J Contemp Dent Pract 2014; 15 (6):812-817.

DOI: 10.5005/jp-journals-10024-1623

Published Online: 01-12-2014

Copyright Statement:  Copyright © 2014; The Author(s).


Abstract

How to cite this article

Awan KH, Patil S, Habib SR, Pejcic A, Zain RB. Evaluation of Medicinal Interventions for the Management of Oral Submucous Fibrosis: A Systematic Review of the Literature. J Contemp Dent Pract 2014;15(6):812-817.


PDF Share
  1. Atrophia idiopathica (tropica) mucosae oris. London: Proceedings of the 11th International Dental Congress. 1952.
  2. Fibrosis of the palate and pillars. Ind J Otolaryngol 1953;4:1.
  3. J Oral Pathol Med 2007 Nov;36(10):575-580.
  4. Oral submucous fibrosis: an unusual disease. JNJ Dent Assoc Spring 1997;68(2):17-19.
  5. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncology 2006 Jul;42(6):561-568.
  6. Oral submucous fibrosis: a review. Annals of the Academy of Medicine, Singapore. 1989 Sep;18(5):603-607.
  7. Submucous fibrosis in Taiwan. Oral Surg Oral Med Oral Pathol 1979 May;47(5):453-457.
  8. Oral submucous fibrosis: its pathogenesis and management. British Dent J 1986 Jun 21;160(12):429-434.
  9. Serum levels of iron and proteins in oral submucous fibrosis (OSMF). Annals of dentistry. Winter 1990;49(2):23-25.
  10. Estimation of major immunoglobulin profile in oral submucous fibrosis by radial immunodiffusion. Int J Oral Surg 1985 Dec;14(6):533-537.
  11. Stabilisation of collagen by betel nut polyphenols as a mechanism in oral submucous fibrosis. Experientia 1987 Apr 15;43(4):391-393.
  12. The oral health consequences of chewing areca nut. Addiction Biology 2002 Jan;7(1):115-125.
  13. Increased lysyl oxidase activity in fibroblasts cultured from oral submucous fibrosis associated with betel nut chewing in Taiwan. J Oral Pathol Med: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1995 Oct;24(9):407-412.
  14. Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis. J Oral Pathol Med 1999 Feb;28(2):59-63.
  15. Oral submucous fibrosis patients have altered levels of cytokine production. Oral Pathol Med: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2000 Mar;29(3):123-128.
  16. Management of oral submucous fibrosis: a conservative approach. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons 1991 Aug;49(8):788-791.
  17. Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases. Journal of oral pathology and medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1995 Oct;24(9):402-406.
  18. Evaluation of multiple micronutrient supplementation in the management of oral submucous fibrosis in Karachi, Pakistan. Nutrition and Cancer. 1997;27(1):41-47.
  19. Clinical experience with the use of peripheral vasodilator in oral disorders. Int J Oral Maxillofac Surg 1987 Dec;16(6):695-699.
  20. Clinical treatment observation of tea pigment for oral submucous fibrosis. Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China J Stomatology 1998 Feb;16(1):50-52.
  21. Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endodont 2007 Feb;103(2):207-213.
  22. Oral submucous fibrosis—a new treatment regimen. J Oral and Maxillofac Surgery 1988 Oct;46(10):830-833.
  23. Oral submucous fibrosis-treatment with hyalase. J Laryngol Otology 1985 Jan;99(1):57-59.
  24. Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Ind J Dental Res 2006 Oct-Dec;17(4):190-198.
  25. Early human safety study of turmeric oil (Curcuma longa oil) administered orally in healthy volunteers. J Association Physicians India 2003 Nov; 51:1055-1060.
  26. Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis. Cancer Letters 1997 Jun 24;116(2):265-269.
  27. Oral administration of milk from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis. J Oral Pathol Med 2001 Nov;30(10):618-625.
  28. Interferon gamma (IFN-gamma) may reverse oral submucous fibrosis. J Oral Pathology Med 2001 Jan;30(1):12-21.
  29. Interventions for the management of oral submucous fibrosis. The Cochrane database of systematic reviews. 2008; (4):CD007156.
  30. Subepithelial changes in oral submucous fibrosis. Acta pathologica et microbiologica Scandinavica 1967;70(2):161-173.
  31. Distribution of procollagen type III, collagen type VI and tenascin in oral submucous fibrosis (OSF). J Oral Pathol Med 1994 Oct;23(9):394-398.
  32. Collagenase activity in oral submucous fibrosis. Proceedings of the National Science Council, Republic of China. Part B, Life Sci 1992 Apr;16(2):106-110.
  33. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis. Oral Oncol 2003 Oct;39(7):728-735.
  34. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis. Oral Oncol 2003 Jun;39(4):367-372.
  35. Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function. Oral Diseases 2007 Jul;13(4):407-413.
  36. Pentoxifylline. J Am Academy of Dermatol 1994 Apr;30(4):603-621.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.